Current approaches to the management of diabetic retinopathy

被引：1

作者：

Demidova, T. Y. ^{[1
]}

Trakhtenberg, Y. A. ^{[2
]}

机构：

[1] Russian Med Acad Postdegree Educ, Moscow, Russia

[2] Ctr Perinatal Care, Moscow, Russia

来源：

DIABETES MELLITUS | 2014年 / 17卷 / 03期

关键词：

diabetic retinopathy; risk factors; diabetic macular oedema; VEGF; fenofibroic acid;

D O I：

10.14341/DM20143122-128

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review reflects the current status of the diabetic retinopathy treatment problem and describes the results of the largest trials on epidemiology, screening and the risk factors for complications. In addition, this article describes the current approaches and treatment options for diabetic retinopathy, including a description of fenofibroic acid with its mechanism of action and data from clinical trials. This article also contains information on antiangiogenic agents for intravitreal administration.

引用

页码：122 / 128

页数：7

共 26 条

[1]

[Anonymous], 2013, PUBL HLTH SCREEN PRO, P121

[2] Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program [J].

Cavallerano, AA ;

Cavallerano, JD ;

Katalinic, P ;

Tolson, AM ;

Aiello, LP ;

Aiello, LM .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (02) :215-223

[3] Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].

Chaturvedi, N ;

Sjolie, AK ;

Stephenson, JM ;

Abrahamian, H ;

Keipes, M ;

Castellarin, A ;

Rogulja-Pepeonik, Z ;

Fuller, JH .

LANCET, 1998, 351 (9095) :28-31

[4] Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials [J].

Chaturvedi, Nish ;

Porta, Massimo ;

Klein, Ronald ;

Orchard, Trevor ;

Fuller, John ;

Parving, Hans Henrik ;

Bilous, Rudy ;

Sjolie, Anne Katrin .

LANCET, 2008, 372 (9647) :1394-1402

[5] Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models [J].

Chen, Ying ;

Hu, Yang ;

Lin, Mingkai ;

Jenkins, Alicia J. ;

Keech, Anthony C. ;

Mott, Robert ;

Lyons, Timothy J. ;

Ma, Jian-xing .

DIABETES, 2013, 62 (01) :261-272

[6] Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. [J].

Chew, Emily Y. ;

Ambrosius, Walter T. ;

Davis, Matthew D. ;

Danis, Ronald P. ;

Gangaputra, Sapna ;

Greven, Craig M. ;

Hubbard, Larry ;

Esser, Barbara A. ;

Lovato, James F. ;

Perdue, Letitia H. ;

Goff, David C., Jr. ;

Cushman, William C. ;

Ginsberg, Henry N. ;

Elam, Marshall B. ;

Genuth, Saul ;

Gerstein, Hertzel C. ;

Schubart, Ulrich ;

Fine, Lawrence J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :233-244

[7] Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy - Early treatment diabetic retinopathy study (ETDRS) report 22 [J].

Chew, EY ;

Klein, ML ;

Ferris, FL ;

Remaley, NA ;

Murphy, RP ;

Chantry, K ;

Hoogwerf, BJ ;

Miller, D .

ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (09) :1079-1084

[8] STANDARDS OF SPECIALIZED DIABETES CARE [J].

Dedov, I. I. ;

Shestakova, M., V .

DIABETES MELLITUS, 2013, 16 :1-119

[9]

Do DV, 2013 ANN M AME AC OP

[10]

DODSON PM, 2009, DIABETIC RETINOPATHY

← 1 2 3 →